Suppr超能文献

利拉鲁肽起始治疗引发的胃轻瘫:一例报告

Gastroparesis With the Initiation of Liraglutide: A Case Report.

作者信息

Almustanyir Sami, Alhabeeb Habeeb, AlHusseini Noara, Al Thow Mohammed

机构信息

Department of Internal Medicine, Ministry of Health, Riyadh, SAU.

Department of Internal Medicine, King Fahad Medical City, Riyadh, SAU.

出版信息

Cureus. 2020 Nov 28;12(11):e11735. doi: 10.7759/cureus.11735.

Abstract

Gastroparesis is a syndrome that is manifested by gastrointestinal symptoms and delayed gastric emptying without evidence of mechanical obstruction. Herein, we present the case of an 18-year-old diabetic female patient who developed clinical features suggestive of gastroparesis after initial doses of liraglutide. Although rare, drug-induced gastroparesis should be contemplated in diabetic patients with a history of recent commencement of liraglutide, particularly at higher doses. Management of drug-induced gastroparesis is largely symptomatic.

摘要

胃轻瘫是一种以胃肠道症状和胃排空延迟为特征且无机械性梗阻证据的综合征。在此,我们报告一例18岁的糖尿病女性患者,在初始剂量使用利拉鲁肽后出现了提示胃轻瘫的临床特征。尽管罕见,但对于近期开始使用利拉鲁肽尤其是高剂量的糖尿病患者,应考虑药物性胃轻瘫的可能性。药物性胃轻瘫的治疗主要是对症治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b3b/7773310/fd6a07fca929/cureus-0012-00000011735-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验